Stay updated on Pembrolizumab for ALL MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s footer revision/version has been updated from v3.5.2 to v3.5.3, reflecting a site/platform release rather than any change to the clinical trial details.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedAdded 'Acute lymphoid leukemia' as a condition term and added a 'Genetic and Rare Diseases Information Center' resource in the Resources section.SummaryDifference0.2%

- Check47 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a maintenance/version bump with no visible changes to study details.SummaryDifference0.1%

- Check54 days agoChange DetectedUpdated site revision from v3.4.2 to v3.4.3; the previous revision tag has been removed.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.4.2 and removed older maintenance notices (v3.4.1) on the page, which are site-wide versioning updates rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.